Cargando…
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
SIMPLE SUMMARY: There is growing interest in identifying the effects of antidiabetic agents on cancer risk, progression, and anti-cancer treatment due to the long-term use of these medications and the inherently increased risk of malignancies in diabetic patients. Tumor development and progression a...
Autores principales: | Busek, Petr, Duke-Cohan, Jonathan S., Sedo, Aleksi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103952/ https://www.ncbi.nlm.nih.gov/pubmed/35565202 http://dx.doi.org/10.3390/cancers14092072 |
Ejemplares similares
-
Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity
por: Sromova, Lucie, et al.
Publicado: (2015) -
Dipeptidyl peptidase IV activity and/or structure homologs: Contributing factors in the pathogenesis of rheumatoid arthritis?
por: Sedo, Aleksi, et al.
Publicado: (2005) -
Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment
por: Krepela, Evzen, et al.
Publicado: (2021) -
A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers
por: Xu, Rongyang, et al.
Publicado: (2023) -
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis
por: Balaziova, Eva, et al.
Publicado: (2021)